Conference:
Restorative Reproductive Medicine Update
Research and Practical Applications

On July 11 2012, Salt Lake City, Utah, USA will be the setting for the Restorative Reproductive Medicine Update and a fundraising Banquet. We look forward to meeting many of you there.

Tuesday July 10 from 6.00 PM to 9.00 PM for the Banquet and Wednesday July 11, 2012 from 8.00 AM to 5.00 PM MDT

Our presenters are world-class and will be outlining the challenges with current standard reproductive care and the solutions with Restorative Reproductive Medicine. Make sure you do not miss out on these incredible presentations:

Conference Presentations Include:

• Maciej Barczentewicz, MD „Latent hyperprolactinemia and infertility” – Prezentacja_PDF_11_07_2012
• Maciej Barczentewicz, MD , Magdalena Machlarz „Food hypersensitivity and dietary intervention in diagnosis and therapy during the treatment of infertility and coexisting diseases„- prezentacja_PDF_11_07_2012
• Joseph B. Stanford, MD, MSPH „iNEST update and interim results (International NaPro Technology Evaluation and Surveillance of Treatment”
• Cristina del Burgo, MD, PhD „The Mediterranean diet and fertility”
• Maria Wolfs, MD „Ovarian hormone replacement: indications, form, outcomes, costs”
• Luke McLindon, MBBS, FRACGP, NFPMC „Addressing relevant clinical questions inRestorative Reproductive Medicine within a challenging environment”
• Phil C. Boyle, MB „NaPro after failed IVF: a study of 405 couples”

Poniższy wykres przedstawia prawidłowy poziom progesteronu – hormonu odpowiedzialnego m.in. za prawidłowy rozwój dziecka w ciąży i jej utrzymanie ciąży. Wskazane jest przebadanie poziomu tegoż hormonu (badanie krwi). Przed planowaniem poczęcia dziecka poziom progesteronu bada się 7-go dnia po owulacji (po skoku temperatury) i powinien wynosić minimum 16 ng/ml. W czasie ciąży zagrożonej albo po wcześniejszym poronieniu wskazane jest badanie poziomu progesteronu co dwa tygodnie i porównywanie z normami dla danego tygodnia ciąży.  Niski poziom progesteronu jest często przyczyną wielu zaburzeń w ciąży a nawet utraty dziecka tj. poronienia.

Normy progesteronu w ciąży, więcej na: https://naprotechnology.com/progesterone/ http://www.naprotechnology.pl/progesterone.php

 Odpowiedni poziom progesteronu w ciąży: Czytaj dalszą część wpisu »

Barbara Luke, Sc.D., M.P.H., Morton B. Brown, Ph.D., Ethan Wantman, M.B.A.,
Avi Lederman, B.A., William Gibbons, M.D., Glenn L. Schattman, M.D.,
Rogerio A. Lobo, M.D., Richard E. Leach, M.D., and Judy E. Stern, Ph.D.

BACKGROUND
Live-birth rates after treatment with assisted reproductive technology have traditionally been reported on a per-cycle basis. For women receiving continued treatment,
cumulative success rates are a more important measure.
METHODS
We linked data from cycles of assisted reproductive technology in the Society for
Assisted Reproductive Technology Clinic Outcome Reporting System database for the
period from 2004 through 2009 to individual women in order to estimate cumulative
live-birth rates. Conservative estimates assumed that women who did not return for
treatment would not have a live birth; optimal estimates assumed that these women
would have live-birth rates similar to those for women continuing treatment.
RESULTS
The data were from 246,740 women, with 471,208 cycles and 140,859 live births.
Live-birth rates declined with increasing maternal age and increasing cycle number
with autologous, but not donor, oocytes. By the third cycle, the conservative and
optimal estimates of live-birth rates with autologous oocytes had declined from
63.3% and 74.6%, respectively, for women younger than 31 years of age to 18.6% and
27.8% for those 41 or 42 years of age and to 6.6% and 11.3% for those 43 years of
age or older. When donor oocytes were used, the rates were higher than 60% and
80%, respectively, for all ages. Rates were higher with blastocyst embryos (day of
transfer, 5 or 6) than with cleavage embryos (day of transfer, 2 or 3). At the third
cycle, the conservative and optimal estimates of cumulative live-birth rates were,
respectively, 42.7% and 65.3% for transfer of cleavage embryos and 52.4% and
80.7% for transfer of blastocyst embryos when fresh autologous oocytes were used.
CONCLUSIONS
Our results indicate that live-birth rates approaching natural fecundity can be achieved
by means of assisted reproductive technology when there are favorable patient and
embryo characteristics. Live-birth rates among older women are lower than those
among younger women when autologous oocytes are used but are similar to the
rates among young women when donor oocytes are used. (Funded by the National
Institutes of Health and the Society for Assisted Reproductive Technology.)

Czytaj więcej: PDF – IVF Paper by Luke 2012

abp Dziega -Slowo -Metropolity – 18_XI_2012 na 33. niedzielę zwykłą

Praca magisterska Pani mgr Katarzyny Ledwig zrealizowana na Wydziale Nauk o Zdrowiu Uniwersytetu Medycznego we Wrocławiu pod kierunkiem Pana prof. dr hab. Mariana Goludy

Diagnostyka i terapia nieplodnosci w NaProTECHNOLOGY-pdf

Upcoming Webinar with the International IRRM http://conta.cc/SY6avD

http://www.iirrm.org/

Pełny tekst

wersja pdf:

Natural Procreative technology for infertility andr ecurrent miscarriage, Outcome in a Canadian family practice_2012

wersja online: